President’s Donald Trump’s budget proposal should be treated as a genuine, credible threat to science, said Richard Klausner, a biotechnology entrepreneur who led NCI through the years of the doubling of the NIH budget.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
